FDA - Guidance For Industry


A Risk-Based Approach to Monitoring

This guidance assists sponsors of clinical investigations in developing risk-based monitoring strategies and plans for investigational studies of medical products, including human drug and biological products, medical devices, and combinations thereof. The overarching goal of this guidance is to enhance human subject protection and the quality of clinical trial data by focusing sponsor oversight on the most important aspects of study conduct and reporting.


This guidance makes clear that sponsors can use a variety of approaches to fulfill their responsibilities for monitoring clinical investigator (CI) conduct and performance in investigational new drug (IND) studies conducted under 21 CFR part 312 or investigational device exemption (IDE) studies conducted under 21 CFR part 812. The guidance describes strategies for monitoring activities that reflect a modern, risk-based approach that focuses on critical study parameters and relies on a combination of monitoring activities to oversee a study effectively. For example, the guidance specifically encourages greater use of centralized monitoring methods where appropriate.


FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Rather, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.


This document is displayed here for educational reference purposes only.

The document can be found on the FDA website at the following downloads site address link:

.

Featured Posts
Categories
  • Facebook page
  • Twitter page
  • Instagram page
  • LinkedIn Social Icon

The UK's largest Independent Clinical Development Organisation that owns a network of sites

Contract Research Organisation

Copyright © 2021 MAC Research Ltd Group |

SMO Services Ltd |   All rights reserved